(Q46879855)

26 December 2017

title

Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease (English)

1 reference

26 December 2017

1 reference

1 reference

4

Subra Kugathasan

1 reference

26 December 2017

Anne M. Griffiths

7

object named as

Anne M Griffiths

1 reference

26 December 2017

Robert N Baldassano

6

object named as

Robert Baldassano

1 reference

26 December 2017

Joel R Rosh

3

object named as

Joel Rosh

1 reference

26 December 2017

author name string

Dan Turner

1

1 reference

26 December 2017

Andrew B Grossman

2

1 reference

26 December 2017

Ashley R Gilman

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

26 December 2017

The American Journal of Gastroenterology

published in

1 reference

26 December 2017

volume

102

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

2804-12; quiz 2803, 2813

1 reference

26 December 2017

Medical therapy for refractory pediatric Crohn's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Inflammatory bowel disease (ulcerative colitis and Crohn's disease): diagnostic criteria and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Clinical longitudinal standards for height and height velocity for North American children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Low-dose oral methotrexate for maintaining Crohn's disease remission: where we stand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Guidelines for the management of rheumatoid arthritis: 2002 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Rational dosing of azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01474.X

10.1111/J.1572-0241.2007.01474.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

release_2gckv3eaybhfbmkkz72ikgsyb4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2gckv3eaybhfbmkkz72ikgsyb4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 December 2017